Ion Beam Applications

IBA Business Update – First Quarter 2022

19 May 2022 01:00:00 By Nasdaq GlobeNewswire

IBA continues to shape the future of proton therapy at ESTRO 2022 Annual Congress

06 May 2022 01:00:00 By Nasdaq GlobeNewswire

IBA Receives Order from CGNNT for a Proteus®PLUS System to be Installed in Yangzhou, China

05 May 2022 01:00:00 By Nasdaq GlobeNewswire

IBA Strengthens its Dosimetry Portfolio with Acquisition of Modus Medical Devices Inc.

03 May 2022 01:00:00 By Nasdaq GlobeNewswire

IBA – Transparency Notification

22 Apr 2022 00:55:00 By Nasdaq GlobeNewswire

IBA and UMC Groningen engage in FLASH irradiation research collaboration for breast cancer

05 Apr 2022 01:00:00 By Nasdaq GlobeNewswire

IBA Reports Full Year 2021 Results

24 Mar 2022 02:00:00 By Nasdaq GlobeNewswire

IBA and Tractebel announce partnership to support proton therapy construction projects

15 Mar 2022 10:00:00 By Nasdaq GlobeNewswire

IBA – ACQUISITION OF OWN SHARES COMPLETION OF THE SHARE BUYBACK PROGRAM

10 Mar 2022 13:25:00 By Nasdaq GlobeNewswire

IBA – Transparency Notification

08 Mar 2022 13:20:00 By Nasdaq GlobeNewswire

Iba – Acquisition of Own Shares

07 Mar 2022 12:32:00 By Nasdaq GlobeNewswire

Iba – Acquisition of Own Shares

28 Feb 2022 12:27:00 By Nasdaq GlobeNewswire

IBA – ACQUISITION OF OWN SHARES

21 Feb 2022 13:11:00 By Nasdaq GlobeNewswire

IBA – ACQUISITION OF OWN SHARES

14 Feb 2022 12:33:00 By Nasdaq GlobeNewswire

IBA and SOGAZ Insurance Group sign contract for Proteus®ONE proton therapy solution in Russia

14 Feb 2022 01:00:00 By Nasdaq GlobeNewswire

IBA – ACQUISITION OF OWN SHARES

07 Feb 2022 12:00:00 By Nasdaq GlobeNewswire

IBA FY21 Trading Update

01 Feb 2022 01:00:00 By Nasdaq GlobeNewswire

IBA – ACQUISITION OF OWN SHARES

31 Jan 2022 12:00:00 By Nasdaq GlobeNewswire

IBA Launches Compact Low-Energy Cyclotron, Cyclone® KEY

26 Jan 2022 09:00:00 By Nasdaq GlobeNewswire

Iba – Acquisition of Own Shares

24 Jan 2022 12:38:00 By Nasdaq GlobeNewswire